Innovent Biologics Inc. (IVBXF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.80
    0.08 (0.63%)
    At close: Oct 03, 2025, 1:56 PM
    12.72
    -0.62%
    After-hours: Oct 02, 2025, 08:00 PM EDT

    Innovent Biologics Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 1.13B -94.63M -1.28B -1.03B -1.37B -2.18B -2.68B -2.73B -1.39B
    Depreciation & Amortization
    		 265.99M 198.67M 381.81M 370.77M 339.48M 276.79M 237.6M 202.17M 118.7M
    Stock-Based Compensation
    		 601.18M 556.52M 644.93M 574.2M 435.31M 469.49M 523.71M 501.57M 486.88M
    Other Working Capital
    		 200.82M 447.7M 550.61M 566.77M -411.58M -313.45M 858.87M 864.46M 444.09M
    Other Non-Cash Items
    		 341.29M 176.65M 100.82M -264.33M -1.06B -460.11M -185.08M 272.01M 985.89M
    Deferred Income Tax
    		 n/a n/a n/a 96.89M -761.46M -757.24M 101.11M 822.5M 882.35M
    Change in Working Capital
    		 -524.35M 449.82M 708.89M 495.09M -85.42M -25.7M 283.34M -271.84M -777.21M
    Operating Cash Flow
    		 1.82B 1.29B 555.07M 147.81M -1.73B -1.92B -1.82B -2.02B -579.52M
    Capital Expenditures
    		 -368.73M -965.66M -1.22B -1.12B -1.07B -896.9M -1.15B -1.07B -803.22M
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 35.64M -465.9M -1.06B 120.72M -23.75M -538.29M -955.41M -1.63B -3.65B
    Investing Cash Flow
    		 -66.93M -1.17B -2.28B -998.66M -1.09B -1.44B -2.1B -2.7B -4.45B
    Debt Repayment
    		 547.98M -330.13M -330.13M n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -245.38M -276.5M 2.41B 2.59B 2.91B 2.89B 723.44M 5B 7.23B
    Financial Cash Flow
    		 302.6M -606.63M 2.08B 2.59B 2.91B 2.89B 723.44M 5B 7.23B
    Net Cash Flow
    		 2.06B -2.23B 190.85M 864.76M -9.89M -171.62M -1.56B -539.5M 166.96M
    Free Cash Flow
    		 1.45B 321.36M -665.93M -971.58M -2.8B -2.82B -2.96B -3.09B -1.38B

    Add to Watchlist